33 Stocks Moving In Wednesday’s Mid-Day Session
Gainers
MDJM Ltd (NASDAQ: MDJH) jumped 27.2% to $2.29 after gaining 10% on Tuesday.
Groupon Responds to Prescience Point’s Call To Disclose Its Stake In SumUp
New Disclosure Paves The Way For Multiple Bullish Catalysts -
<span class="legendSpanClass">-Updated Price Target of $69.92 -</span>
BATON ROUGE, La., Feb. 2, 2022 /PRNewswire/ -- Prescience
Why Groupon Shares Are Trading Higher Today
Groupon Inc (NASDAQ: GRPN) is trading higher Monday after Prescience Point Capital Management raised its price target on the stock to $88.17.
Prescience Point Capital Management Tweets ‘We’ve had a constructive dialogue with $GRPN 13d filer @absurdtrader and agree on all points. Read our initiation thesis, now moreso a certainty, here: ‘
https://twitter.com/PresciencePoint/status/1486772619621933057
10 Consumer Discretionary Stocks With Whale Alerts In Today’s Session
This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Watching Groupon Shares Following Bloomberg Report ‘Payments Firm SumUp Seeks New Funds at $22 Billion Value’; NOTE: Groupon Holds Stake In SumUp.
https://www.bloomberg.com/news/articles/2022-01-26/payments-firm-sumup-said-to-seek-new-funds-at-22-billion-value
10 Consumer Discretionary Stocks With Whale Alerts In Today’s Session
This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
61 Biggest Movers From Yesterday
Gainers
Genprex, Inc. (NASDAQ: GNPX) shares surged 167.2% to settle at $3.50 on Monday. The FDA granted Fast Track Designation for Genprex’s lead drug candidate, Reqorsa Immunogene combination therapy.
35 Stocks Moving In Monday’s Mid-Day Session
Gainers
Immix Biopharma, Inc. (NASDAQ: IMMX) shares climbed 110.3% to $7.32. The FDA granted Rare Pediatric Disease (RPD) designation to newly listed Immix Biopharma's IMX-110 for rhabdomyosarcoma, a form of pediatric cancer.
Watching Groupon Shares; Prescience Point Capital Management Tweets ‘What is $GRPN ‘s @SumUp stake worth? We believe $GRPN ‘s investment in SumUp is worth multiples of its current book value of ~$123 million, and may be worth upwards of $480 million…..
https://twitter.com/PresciencePoint/status/1476563823452508163